544 related articles for article (PubMed ID: 28919059)
1. Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease: a longitudinal retrospective study.
Josephs KA; Dickson DW; Tosakulwong N; Weigand SD; Murray ME; Petrucelli L; Liesinger AM; Senjem ML; Spychalla AJ; Knopman DS; Parisi JE; Petersen RC; Jack CR; Whitwell JL
Lancet Neurol; 2017 Nov; 16(11):917-924. PubMed ID: 28919059
[TBL] [Abstract][Full Text] [Related]
2. Protein contributions to brain atrophy acceleration in Alzheimer's disease and primary age-related tauopathy.
Josephs KA; Martin PR; Weigand SD; Tosakulwong N; Buciuc M; Murray ME; Petrucelli L; Senjem ML; Spychalla AJ; Knopman DS; Boeve BF; Petersen RC; Parisi JE; Dickson DW; Jack CR; Whitwell JL
Brain; 2020 Dec; 143(11):3463-3476. PubMed ID: 33150361
[TBL] [Abstract][Full Text] [Related]
3. Effect Modifiers of TDP-43-Associated Hippocampal Atrophy Rates in Patients with Alzheimer's Disease Neuropathological Changes.
Buciuc M; Wennberg AM; Weigand SD; Murray ME; Senjem ML; Spychalla AJ; Boeve BF; Knopman DS; Jack CR; Kantarci K; Parisi JE; Dickson DW; Petersen RC; Whitwell JL; Josephs KA
J Alzheimers Dis; 2020; 73(4):1511-1523. PubMed ID: 31929165
[TBL] [Abstract][Full Text] [Related]
4. TDP-43 Is Associated with Subiculum and Cornu Ammonis 1 Hippocampal Subfield Atrophy in Primary Age-Related Tauopathy.
Youssef H; Gatto RG; Pham NTT; Petersen RC; Machulda MM; Reichard RR; Dickson DW; Jack CR; Whitwell JL; Josephs KA
J Alzheimers Dis; 2024; 99(3):1023-1032. PubMed ID: 38728190
[TBL] [Abstract][Full Text] [Related]
5. Association of Apolipoprotein E ε4 With Transactive Response DNA-Binding Protein 43.
Wennberg AM; Tosakulwong N; Lesnick TG; Murray ME; Whitwell JL; Liesinger AM; Petrucelli L; Boeve BF; Parisi JE; Knopman DS; Petersen RC; Dickson DW; Josephs KA
JAMA Neurol; 2018 Nov; 75(11):1347-1354. PubMed ID: 30422173
[TBL] [Abstract][Full Text] [Related]
6. Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study.
Whitwell JL; Dickson DW; Murray ME; Weigand SD; Tosakulwong N; Senjem ML; Knopman DS; Boeve BF; Parisi JE; Petersen RC; Jack CR; Josephs KA
Lancet Neurol; 2012 Oct; 11(10):868-77. PubMed ID: 22951070
[TBL] [Abstract][Full Text] [Related]
7. TDP-43 and Alzheimer's Disease Pathologic Subtype in Non-Amnestic Alzheimer's Disease Dementia.
Sahoo A; Bejanin A; Murray ME; Tosakulwong N; Weigand SD; Serie AM; Senjem ML; Machulda MM; Parisi JE; Boeve BF; Knopman DS; Petersen RC; Dickson DW; Whitwell JL; Josephs KA
J Alzheimers Dis; 2018; 64(4):1227-1233. PubMed ID: 30010126
[TBL] [Abstract][Full Text] [Related]
8. Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART).
Josephs KA; Murray ME; Tosakulwong N; Whitwell JL; Knopman DS; Machulda MM; Weigand SD; Boeve BF; Kantarci K; Petrucelli L; Lowe VJ; Jack CR; Petersen RC; Parisi JE; Dickson DW
Acta Neuropathol; 2017 May; 133(5):705-715. PubMed ID: 28160067
[TBL] [Abstract][Full Text] [Related]
9. Brain atrophy in primary age-related tauopathy is linked to transactive response DNA-binding protein of 43 kDa.
Josephs KA; Murray ME; Tosakulwong N; Weigand SD; Knopman DS; Petersen RC; Jack CR; Whitwell JL; Dickson DW
Alzheimers Dement; 2019 Jun; 15(6):799-806. PubMed ID: 31056344
[TBL] [Abstract][Full Text] [Related]
10. TDP-43-associated atrophy in brains with and without frontotemporal lobar degeneration.
Buciuc M; Martin PR; Tosakulwong N; Murray ME; Petrucelli L; Senjem ML; Spychalla AJ; Knopman DS; Boeve BF; Petersen RC; Parisi JE; Reichard RR; Dickson DW; Jack CR; Whitwell JL; Josephs KA
Neuroimage Clin; 2022; 34():102954. PubMed ID: 35168140
[TBL] [Abstract][Full Text] [Related]
11. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study.
Murray ME; Graff-Radford NR; Ross OA; Petersen RC; Duara R; Dickson DW
Lancet Neurol; 2011 Sep; 10(9):785-96. PubMed ID: 21802369
[TBL] [Abstract][Full Text] [Related]
12. The hippocampal longitudinal axis-relevance for underlying tau and TDP-43 pathology.
Lladó A; Tort-Merino A; Sánchez-Valle R; Falgàs N; Balasa M; Bosch B; Castellví M; Olives J; Antonell A; Hornberger M
Neurobiol Aging; 2018 Oct; 70():1-9. PubMed ID: 29935415
[TBL] [Abstract][Full Text] [Related]
13. Antemortem volume loss mirrors TDP-43 staging in older adults with non-frontotemporal lobar degeneration.
Bejanin A; Murray ME; Martin P; Botha H; Tosakulwong N; Schwarz CG; Senjem ML; Chételat G; Kantarci K; Jack CR; Boeve BF; Knopman DS; Petersen RC; Giannini C; Parisi JE; Dickson DW; Whitwell JL; Josephs KA
Brain; 2019 Nov; 142(11):3621-3635. PubMed ID: 31562527
[TBL] [Abstract][Full Text] [Related]
14. Associations between hippocampal morphometry and neuropathologic markers of Alzheimer's disease using 7 T MRI.
Blanken AE; Hurtz S; Zarow C; Biado K; Honarpisheh H; Somme J; Brook J; Tung S; Kraft E; Lo D; Ng DW; Vinters HV; Apostolova LG
Neuroimage Clin; 2017; 15():56-61. PubMed ID: 28491492
[TBL] [Abstract][Full Text] [Related]
15. TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia.
James BD; Wilson RS; Boyle PA; Trojanowski JQ; Bennett DA; Schneider JA
Brain; 2016 Nov; 139(11):2983-2993. PubMed ID: 27694152
[TBL] [Abstract][Full Text] [Related]
16. TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's syndrome: association with age, hippocampal sclerosis and clinical phenotype.
Davidson YS; Raby S; Foulds PG; Robinson A; Thompson JC; Sikkink S; Yusuf I; Amin H; DuPlessis D; Troakes C; Al-Sarraj S; Sloan C; Esiri MM; Prasher VP; Allsop D; Neary D; Pickering-Brown SM; Snowden JS; Mann DM
Acta Neuropathol; 2011 Dec; 122(6):703-13. PubMed ID: 21968532
[TBL] [Abstract][Full Text] [Related]
17. The diffeomorphometry of regional shape change rates and its relevance to cognitive deterioration in mild cognitive impairment and Alzheimer's disease.
Tang X; Holland D; Dale AM; Younes L; Miller MI;
Hum Brain Mapp; 2015 Jun; 36(6):2093-117. PubMed ID: 25644981
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE ε4 haplotype status: a community-based cohort study.
Yang HS; Yu L; White CC; Chibnik LB; Chhatwal JP; Sperling RA; Bennett DA; Schneider JA; De Jager PL
Lancet Neurol; 2018 Sep; 17(9):773-781. PubMed ID: 30093249
[TBL] [Abstract][Full Text] [Related]
19. Contribution of mixed pathology to medial temporal lobe atrophy in Alzheimer's disease.
de Flores R; Wisse LEM; Das SR; Xie L; McMillan CT; Trojanowski JQ; Robinson JL; Grossman M; Lee E; Irwin DJ; Yushkevich PA; Wolk DA
Alzheimers Dement; 2020 Jun; 16(6):843-852. PubMed ID: 32323446
[TBL] [Abstract][Full Text] [Related]
20. Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer's disease continuum.
Allison SL; Koscik RL; Cary RP; Jonaitis EM; Rowley HA; Chin NA; Zetterberg H; Blennow K; Carlsson CM; Asthana S; Bendlin BB; Johnson SC
Neuroimage Clin; 2019; 23():101895. PubMed ID: 31252287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]